Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 8 Jan 2022 - 14 Jan 2022
STUDY TYPE:Human Studies
DATE PUBLISHED: 2021 Dec
JOURNAL:Neurol Clin Pract
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/34992966?dopt=Abstract
Volume:11
ISSUE:6
To assess migraine outcome after 12-month treatment with erenumab and compare patients who underwent 3-month erenumab discontinuation following the first treatment cycle with those who continued monthly administrations.